Can we effectively prevent cancer (or it’s recurrence) – and if so, how? The Tumor Microenvironment (TME) is a critical battleground between preserving normal non-cancer cell growth and opposing aggressive cancer stem cell activity and recruitment. The mechanisms of the TME and normal versus cancerous tissue interaction will be described. Conditions that affect this battle will be outlined and the relationship to primary and secondary cancer prevention will be discussed.

Learning Objectives:

• Describe the components of the TME
• Discuss the function of the TME
• Describe the interrelationship of the TME and CSC’s
• Discuss therapies

CME Effective Date:

Live Event: May 19th, 2026

CME Expiration Date:

Live Event: June 19th, 2026

Educational Credits:

1.5 AMA/PRA Category 1 CME Credit™
1.5 Nursing Contact Hours (1.0 Pharmacologic Hours)

Target Audience:

This program is intended for: Physicians (MD, ND, Other), Nurses, Nurse Practitioners, and Other Healthcare professionals

Conflict of Interest Disclosure Policy

Identify, Mitigate, and Disclose Relevant Financial Relationships

Many healthcare professionals have financial relationships with ineligible companies.  These relationships must not be allowed to influence accredited continuing education.  The Foundation for Care Management (FCM) as the accredited provider is responsible for identifying relevant financial relationships between individuals in control of educational content and ineligible companies and managing these to ensure they do not introduce commercial bias into the education. Financial relationships are defined as relevant if the educational content is related to the business lines or products of the ineligible company.  As an accredited provider FCM collects information from planners, faculty and others in control of educational content and conducts an extensive review process.  Financial relationships are identified, reviewed and mitigated.  In some cases. speakers and committee members may be excluded.  All relevant financial relationships are disclosed to the learner below as required by the ACCME.

Disclosures:

Planner/Presenter: Dr. Paul Anderson discloses the following: NFH – Vitazan; Science Advisory Board Member, MD Lifespan; Science Advisory Board Member, Priority One; Formulation Advisor.

Reviewers: Kenneth Meyer discloses no financial relationships with any ineligible companies.

Accreditation Statement: